Effects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk-hydroxyapatite films

Acta Biomaterialia

Volumn 10, Issue 1, 2014, Pages 486-493

  Hayden, Rebecca S ^a   Vollrath, Moritz ^a   Kaplan, David L ^a  

^a Tufts University   (United States)

Author keywords

Bisphosphonates; Co culture; Osteoporosis; Silk

Indexed keywords

BIOMATERIALS; BONE; CALCIUM; CELL CULTURE; DEPOSITION; HYDROXYAPATITE; METABOLISM; OSTEOBLASTS; PHOSPHATASES; STEM CELLS;

ALENDRONATE; BISPHOSPHONATES; CALCIUM DEPOSITION; CO-CULTURES; HYDROXYAPATITE FILMS; IN-VITRO; METABOLIC ACTIVITY; MIMETICS; OSTEOBLAST CULTURES; SILK;

DISEASES;

ALENDRONIC ACID; ALKALINE PHOSPHATASE; CALCIUM; CLODRONIC ACID; HYDROXYAPATITE; SILK;

ACUTE MONOCYTIC LEUKEMIA; ARTICLE; BONE REMODELING; CELL METABOLISM; CELL STRUCTURE; COCULTURE; CONTROLLED STUDY; DRUG INDICATION; ENZYME ACTIVITY; FILM; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MESENCHYMAL STEM CELL; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; PRIORITY JOURNAL;

BISPHOSPHONATES; CO-CULTURE; OSTEOPOROSIS; SILK;

ALENDRONATE; ANIMALS; BOMBYX; CALCIUM; CLODRONIC ACID; COCULTURE TECHNIQUES; DIPHOSPHONATES; DURAPATITE; HUMANS; OSTEOBLASTS; OSTEOCLASTS; SILK; SURFACE PROPERTIES;

EID: 84888636876     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2013.09.028     Document Type: Article

References (46)

1. S. Boonen, R.F. Laan, I.P. Barton, and N.B. Watts Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies Osteoporos Int 16 2005 1291 1298
2. J. Schilcher, K. Michaëlsson, and P. Aspenberg Bisphosphonate use and atypical fractures of the femoral shaft N Engl J Med 364 2011 1728 1737
3. V.M. Cartsos, S. Zhu, and A.I. Zavras Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people J Am Dent Assoc 139 2008 23 30
4. M. Whitaker, J. Guo, T. Kehoe, and G. Benson Bisphosphonates for osteoporosis - where do we go from here? N Engl J Med 366 2012 2048 2051
5. D. Black, and D. Bauer Continuing bisphosphonate treatment for ssteoporosis - for whom and for how long? N Engl J Med 366 2012 2051 2053
6. B. Abrahamsen Are long-term bisphosphonate users a reality? Dose years for current bisphosphonate users assessed using the danish national prescription database Osteoporos Int 2012 10 13
7. G.A. Rodan, and H.A. Fleisch Bisphosphonates: mechanisms of action J Clin Invest 97 1996 2692 2696
8. D.B. Kimmel Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates J Dent Res 86 2007 1022 1033
9. M. Nishikawa Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures Bone 18 1996 9 14
10. H.C. Tenenbaum, M. Torontali, and B. Sukhu Effects of bisphosphonates and inorganic pyrophosphate on osteogenesis in vitro Bone 13 1992 249 255
11. M. Sahni, H.L. Guenther, H. Fleisch, P. Collin, and T.J. Martin Bisphosphonates act on rat bone resorption through the mediation of osteoblasts J Clin Invest 91 1993 2004 2011
12. J.-Y. Ohe, Y.-D. Kwon, and H.-W. Lee Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts Clin Oral Investig 16 2012 1153 1159
13. V. Viereck, G. Emons, V. Lauck, K.-H. Frosch, S. Blaschke, and C. Gründker Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts Biochem Biophys Res Commun 291 2002 680 686
14. T. Bellido, and L.I. Plotkin Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability Bone 49 2011 50 55
15. L.I. Plotkin, R.S. Weinstein, A.M. Parfitt, P.K. Roberson, S.C. Manolagas, and T. Bellido Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin J Clin Invest 104 1999 1363 1374
16. E. Boanini, P. Torricelli, M. Gazzano, M. Fini, and A. Bigi The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro Biomaterials 33 2012 722 730
17. E. Boanini, P. Torricelli, M. Gazzano, M. Fini, and A. Bigi The effect of alendronate doped calcium phosphates on bone cells activity Bone 51 2012 944 952
18. E. Boanini, P. Torricelli, M. Gazzano, M. Fini, and A. Bigi Crystalline calcium alendronate obtained by octacalcium phosphate digestion: a new chance for local treatment of bone loss diseases? Adv Mater 25 2013 4605 4611
19. G.H. Altman Cell differentiation by mechanical stress FASEB J 16 2002 270 272
20. S. Bhumiratana, W.L. Grayson, A. Castaneda, D.N. Rockwood, E.S. Gil, and D.L. Kaplan Nucleation and growth of mineralized bone matrix on silk-hydroxyapatite composite scaffolds Biomaterials 32 2011 2812 2820
21. S. Sengupta, S.-H. Park, G.E. Seok, A. Patel, K. Numata, and C.-L. Lu Quantifying osteogenic cell degradation of silk biomaterials Biomacromolecules 11 2010 3592 3599
22. U.-J. Kim, J. Park, H.J. Kim, M. Wada, and D.L. Kaplan Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin Biomaterials 26 2005 2775 2785
23. H.-J. Jin, J. Park, V. Karageorgiou, U.-J. Kim, R. Valluzzi, and P. Cebe Water-stable silk films with reduced β-sheet content Adv Funct Mater 15 2005 1241 1247
24. J. Kuljanin, I. Janković, J. Nedeljković, D. Prstojević, and V. Marinković Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions J Pharm Biomed Anal 28 2002 1215 1220
25. E.A. Taha, and N.F. Youssef Spectrophotometric determination of some drugs for osteoporosis Chem Pharm Bull 51 2003 1444 1447
26. I.U. Petersson, J.E.L. Löberg, A.S. Fredriksson, and E.K. Ahlberg Semi-conducting properties of titanium dioxide surfaces on titanium implants Biomaterials 30 2009 4471 4479
27. O.P. Mills, and W.I. Rose Shape and surface area measurements using scanning electron microscope stereo-pair images of volcanic ash particles Geosphere 6 2010 805 811
28. X. Chen, H. Ostadi, and K. Jiang Three-dimensional surface reconstruction of diatomaceous frustules Anal Biochem 403 2010 63 66
29. H. Ostadi, K. Jiang, and P.D. Prewett Characterisation of FIB milling yield of metals by SEM stereo imaging technique Microelectron Eng 86 2009 1021 1024
30. L. Meinel Silk implants for the healing of critical size bone defects Bone 37 2005 688 698
31. C. Kirker-Head BMP-silk composite matrices heal critically sized femoral defects Bone 41 2007 247 255
32. B.B. Mandal, A. Grinberg, E.S. Gil, B. Panilaitis, and D.L. Kaplan High-strength silk protein scaffolds for bone repair Proc Natl Acad Sci U S A 109 2012 7699 7704
33. J.E. Moreau, K. Anderson, J.R. Mauney, T. Nguyen, D.L. Kaplan, and M. Rosenblatt Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model Cancer Res 67 2007 10304 10308
34. R. Goldstein, M. Reagan, K. Anderson, and D. Kaplan Human bone marrow - derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis Cancer Res 70 2010 10044 10050
35. L. Sun, X. Wang, and D.L. Kaplan A 3D cartilage - inflammatory cell culture system for the modeling of human osteoarthritis Biomaterials 32 2011 5581 5589
36. R.S. Hayden, J.-P. Fortin, B. Harwood, B. Subramanian, K.P. Quinn, and I. Georgakoudi Cell-tethered ligands modulate bone remodeling by osteoblasts and osteoclasts Adv Funct Mater 2013 (advance online publication)
37. M.J. Rogers From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates Calcif Tissue Int 75 2004 451 461
38. M. Kellinsalmi, H. Mönkkönen, J. Mönkkönen, H.-V. Leskelä, V. Parikka, and M. Hämäläinen In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts Basic Clin Pharmacol Toxicol 97 2005 382 391
39. G.B. Kasting, and M.D. Francis Retention of etidronate in human, dog, and rat J Bone Miner Res 7 1992 513 522
40. G. Duque, and D. Rivas Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells J Bone Miner Res 22 2007 1603 1611
41. G.-I. Im, S.A. Qureshi, J. Kenney, H.E. Rubash, and A.S. Shanbhag Osteoblast proliferation and maturation by bisphosphonates Biomaterials 25 2004 4105 4115
42. A.I. Idris, J. Rojas, I.R. Greig, R.J. Van't Hof, and S.H. Ralston Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro Calcif Tissue Int 82 2008 191 201
43. A.I. Idris, I.R. Greig, E. Bassonga-Landao, S.H. Ralston, and R.J. Van't Hof Identification of novel biphenyl carboxylic acid derivatives as novel antiresorptive agents that do not impair parathyroid hormone-induced bone formation Endocrinology 150 2009 5 13
44. C. García-Moreno Effect of alendronate on cultured normal human osteoblasts Bone 22 1998 233 239
45. E. Boanini, P. Torricelli, M. Gazzano, R. Giardino, and A. Bigi Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells Biomaterials 29 2008 790 796
46. S.L. Silverman, N.B. Watts, P.D. Delmas, J.L. Lange, and R. Lindsay Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study Osteoporos Int 18 2007 25 34